Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia
Status:
Completed
Trial end date:
2004-10-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the safety of telithromycin (HMR3647) 20 mg/kg qd for 5-7
days in children with community-acquired pneumonia (CAP).
Secondary objectives are to assess Pharmacokinetics, Efficacy and Acceptability of
telithromycin 20 mg/kg qd for 5-7 days in children with CAP.